Modafinil
Back to searchMolecule Structure
Scientific Name
Modafinil
Description of the Drug
Modafinil is a stimulant used to improve wakefulness in patients with sleep apnea, narcolepsy, or shift work disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00745
http://www.drugbank.ca/drugs/DB00745
Brand Name(s)
Modafinil, Provigil
Company Owner(s)
Cadila Healthcare Ltd, Apotex Inc, Alembic Pharmaceuticals Ltd, Cephalon Inc, Watson Laboratories Inc, Aurobindo Pharma Ltd, Hikma Pharmaceuticals, Orbion Pharmaceuticals Private Ltd, Mylan Pharmaceuticals Inc, Appco Pharma Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Dopamine transporter | SINGLE PROTEIN | INHIBITOR | CHEMBL238 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL34488 | |
| PharmGKB | PA450530 | |
| Human Metabolome Database | HMDB0014883 | |
| DrugBank | DB00745 | |
| PubChem: Thomson Pharma | 14897309 | |
| PubChem | 4236 | |
| Mcule | MCULE-6678415272 | |
| LINCS | LSM-1343 | |
| Nikkaji | J33.118J | |
| BindingDB | 50156055 | |
| EPA CompTox Dashboard | DTXSID0023329 | |
| DrugCentral | 1826 | |
| Guide to Pharmacology | 7555 | |
| rxnorm | MODAFINIL | PROVIGIL |
| PubChem: Drugs of the Future | 12014011 | |
| ChEBI | 77585 |
